CAN A CARDIAC PEPTIDE PREDICT MORTALITY IN HUMAN HYPERTENSION?: NT-proBNP and mortality risk in hypertension

od Cannone, Valentina, McKie, Paul M., Burnett, John C.
Izdano 2011

A Contemporary Systematic Approach to Assessing the Patient with Heart Failure with Reduced Ejection Fraction: Multimodal Noninvasive and Invasive Evaluation

od Wan, Siu-Hin, McKie, Paul M., Bois, John P.
izdano v Cardiol Res Pract (2019)

Rationale and Design of a Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy of B-type Natriuretic Peptide For the Preservation of Left Ventricula...

od Sangaralingham, S. Jeson, Burnett, John C., McKie, Paul M., Schirger, John A., Chen, Horng H.
Izdano 2013

M-atrial natriuretic peptide and nitroglycerin in experimental acute hypertensive heart failure: differential actions of two cGMP activating therapeutics

od McKie, Paul M, Cataliotti, Alessandro, Ichiki, Tomoko, Sangaralingham, S Jeson, Chen, Horng H, Burnett, John C
Izdano 2013

M‐Atrial Natriuretic Peptide and Nitroglycerin in a Canine Model of Experimental Acute Hypertensive Heart Failure: Differential Actions of 2 cGMP Activating Therapeutics

od McKie, Paul M., Cataliotti, Alessandro, Ichiki, Tomoko, Sangaralingham, S. Jeson, Chen, Horng H., Burnett, John C.
Izdano 2014

The Effects of Furosemide Dose Reduction on Glomerular Filtration Rate in Stable Systolic Heart Failure

od McKie, Paul M., Schirger, John A., Benike, Sherry L., Harstad, Lynn K., Chen, Horng H.
izdano v JACC Heart Fail (2014)

Synchronous neurology–primary care collaboration in a medical home

od Young, Nathan P., Burkholder, David B., Philpot, Lindsey M., McKie, Paul M., Ebbert, Jon O.
izdano v Neurol Clin Pract (2020)

STOP-HF Trial: Higher Endogenous BNP and Cardiovascular Protection in Subjects at Risk for Heart Failure

od Cannone, Valentina, Ledwidge, Mark, Watson, Chris, McKie, Paul M., Burnett, John C., McDonald, Kenneth
izdano v JACC Basic Transl Sci (2021)

A HUMAN ATRIAL NATRIURETIC PEPTIDE GENE MUTATION REVEALS A NOVEL PEPTIDE WITH ENHANCED BLOOD PRESSURE LOWERING, RENAL ENHANCING, AND ALDOSTERONE SUPPRESSING ACTIONS

od McKie, Paul M, Cataliotti, Alessandro, Huntley, Brenda K, Martin, Fernando L, Olson, Timothy M, Burnett, John C
Izdano 2009

Cenderitide, a novel dual GC-A and GC-B receptor activator, is a potent chronic cardiorenal fibroinhibiting peptide which suppresses aldosterone and reduces proteinuria in models o...

od Martin, Fernando L, McKie, Paul M, Sangaralingham, Jeson S, Ichiki, Tomoko, Harders, Gerald E, Chen, Horng H, Burnett, John C
Izdano 2011

A NOVEL ATRIAL NATRIURETIC PEPTIDE BASED THERAPEUTIC IN EXPERIMENTAL ANGIOTENSIN II MEDIATED ACUTE HYPERTENSION

od McKie, Paul M., Cataliotti, Alessandro, Boerrigter, Guido, Chen, Horng H., Sangaralingham, S. Jeson, Martin, Fernando L., Ichiki, Tomoko, Burnett, John C.
izdano v Hypertension (2010)

Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis

od Ichiki, Tomoko, Boerrigter, Guido, Huntley, Brenda K., Sangaralingham, S. Jeson, McKie, Paul M., Harty, Gail J., Harders, Gerald E., Burnett, John C.
Izdano 2013

Urinary C-type natriuretic peptide excretion: a potential novel biomarker for renal fibrosis during aging

od Jeson Sangaralingham, S., Heublein, Denise M., Grande, Joseph P., Cataliotti, Alessandro, Rule, Andrew D., McKie, Paul M., Martin, Fernando L., Burnett, John C.
Izdano 2011

C-Type natriuretic peptide: a potential urinary biomarker for renal remodeling and fibrosis during aging

od Sangaralingham, Jeson S, Heublein, Denise M, Grande, Joseph P, Cataliotti, Alessandro, Rule, Andrew D, McKie, Paul M, Martin, Fernando L, Burnett, John C
Izdano 2011

Predictive Utility of Atrial, N-Terminal Pro-Atrial, and N-Terminal Pro-B-Type Natriuretic Peptides for Mortality and Cardiovascular Events in the General Community: A 9-Year Follo...

od McKie, Paul M., Cataliotti, Alessandro, Sangaralingham, S. Jeson, Ichiki, Tomoko, Cannone, Valentina, Bailey, Kent R., Redfield, Margaret M., Rodeheffer, Richard J., Burnett, John C.
Izdano 2011

The Prognostic Value of N-Terminal Pro–B-Type Natriuretic Peptide for Death and Cardiovascular Events in Healthy Normal and Stage A/B Heart Failure Subjects

od McKie, Paul M., Cataliotti, Alessandro, Lahr, Brian D., Martin, Fernando L., Redfield, Margaret M., Bailey, Kent R., Rodeheffer, Richard J., Burnett, John C.
Izdano 2010

High-Sensitivity Troponin I and Amino-Terminal Pro–B-Type Natriuretic Peptide Predict Heart Failure and Mortality in the General Population

od McKie, Paul M., AbouEzzeddine, Omar F., Scott, Christopher G., Mehta, Ramila, Rodeheffer, Richard J., Redfield, Margaret M., Burnett, John C., Jaffe, Allan S.
izdano v Clin Chem (2014)

Effect of integrated community neurology on utilization, diagnostic testing, and access

od Elrashidi, Muhamad Y., Philpot, Lindsey M., Young, Nathan P., Ramar, Priya, Swanson, Kristi M., McKie, Paul M., Crane, Sarah J., Ebbert, Jon O.
izdano v Neurol Clin Pract (2017)

Impact of electronic clinical decision support on adherence to guideline-recommended treatment for hyperlipidaemia, atrial fibrillation and heart failure: protocol for a cluster ra...

od Kessler, Maya Elizabeth, Carter, Rickey E, Cook, David A, Kor, Daryl Jon, McKie, Paul M, Pencille, Laurie J, Scheitel, Marianne R, Chaudhry, Rajeev
izdano v BMJ Open (2017)

Getting to the Heart of the Matter: A Triage Model to Improve Utilization of Cardiology Consultative Services

od Agor, Joseph K., Sir, Mustafa Y., Pasupathy, Kalyan S., Foley, David A., Scott, Christopher G., Elrashidi, Muhamad Y., Young, Nathan P., McKie, Paul M.
izdano v Mayo Clin Proc Innov Qual Outcomes (2019)